Dubai, April 12 -- Dr Huzaifa Khorakiwala, Executive Director of Wockhardt Limited, on Saturday said that imposition of US reciprocal tariffs, if extended on the Indian pharmaceutical products, will pose a significant challenge on the industry.

"If tariffs come, it's not an opportunity; it is a challenge, and it is how you address the challenge that is the question," he said.

US President Donald Trump's reciprocal tariff announcement last week has been sending tremors globally, including here in India. However, in recent developments, Trump announced on Wednesday a 90-day pause on tariffs against all countries except China for negotiating tariffs. He has also said that the US will soon announce major tariffs on pharma products.

Going f...